Skip to main content
Industry News
SNMMI backs Technegas fast-track review for V/Q scans
1/22/2021

SNMMI sent a letter to the FDA recommending initiation of a fast-track review of Cyclopharm's Technegas agent used for nuclear medicine ventilation/perfusion lung scans. Speedy approval of Technegas is vital because of the decrease in V/Q studies focused on the ventilation portion since the COVID-19 pandemic started, SNMMI said.

Full Story: